EFSA Evaluates Extended Use of Pasteurised Akkermansia muciniphila as a Novel Food
On September 25, 2025, the European Food Safety Authority (EFSA) announced that its Panel on Nutrition, Novel Foods and Food Allergens (NDA) had published a scientific opinion regarding the extension of use of pasteurised Akkermansia muciniphila as a novel food (NF) under Regulation (EU) 2015/2283.
This latest assessment was conducted at the request of the European Commission and focused on expanding the NF’s intended use to include food supplements and Foods for Special Medical Purposes (FSMPs) for two additional population groups:
-
Adolescents aged 12 to <18 years, and
-
Pregnant and lactating women.
The proposed maximum daily dose corresponds to approximately 4.8 × 10⁸ cells per kilogram of body weight per day, which aligns with the safe level previously established in 2021 by the same EFSA Panel.
After reviewing new toxicological and human studies on A. muciniphila (including the specific strain used in the NF), EFSA concluded that no new safety concerns were identified for its use in adolescents. Accordingly, the NF is considered safe at doses up to 2.1 × 10¹⁰ cells/day for adolescents aged 12 to <14 years, and 3.0 × 10¹⁰ cells/day for those aged 14 to <18 years.
However, EFSA emphasized that no sufficient evidence was provided to establish the safety of the NF in pregnant or lactating women. Therefore, its use in these populations cannot be recommended based on the current data.
This opinion reaffirms EFSA’s cautious but science-based approach toward microbiome-related novel foods, ensuring that extended uses remain within well-characterized and safe exposure limits.
2026-10-28
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
FDA Dye Phase-Out Push Opens a Bigger Window for Natural Color Solutions
-
Glyphosate Faces New UK Pressure as EU Trade Alignment Returns to the Debate
-
U.S. API Dependence Turns Pharmaceutical Ingredients Into a National Security Issue
-
Pharma Tariff Risk Pushes Global Drugmakers to Rebuild U.S. Supply Chains
-
MDI Price Surge Hits EMEAI: Is This a Market Correction or the Beginning of a Supply Crisis?
-
“Deregulation” or “Concession”? The Hidden Crisis Behind India’s Repeal of QCOs on Seven Key Petrochemicals
-
Oil-Coal Price Gap Widens! Coal Chemical Enterprises See Significant Profit Surge in H1 2026
-
China's National Narcotics Control Commission Issues Important Notice: Beware of These 8 Chemicals Being Diverted for Drug Production
-
Explosions Reported Near Saudi Aramco Headquarters as Missile Is Intercepted Over Dhahran
-
European Petrochemicals Enter 'Era of Downsizing' as Dow, TotalEnergies, Shell Exit Older Cracker Assets
Recommend Reading
-
“Soaring Sulfuric Acid, Tightening Ore Supplies”: The High-Stakes Battle Behind the Titanium Dioxide Price Surge
-
From Coffee Waste to Superfood Additive: EU Declares Pectin-Rich Arabica Extract Safe for Food Use
-
Australia Approves Lab-Grown “Milk Sugar” for Babies—A Breakthrough in Infant Nutrition
-
“Milk Sugar 2.0” Cleared for Takeoff: EU Greenlights Next-Gen Human-Identical Oligosaccharide for Infant Nutrition
-
Glenmark’s $1 Billion Cancer Bet: Oncology Revolution Set to Ignite in FY28
-
Premium Global Chemical Sourcing Requests (24-28 Nov 2025)
-
Cost Side Stops Falling and Rebounds; PC Prices Stabilize and Consolidate in November
-
On January 30, the price of pure benzene in China increased
-
Polyester Bottle Flakes in January Show Initial Weakness, Then Strengthen, Climbing to a Peak at Month’s End Before Reversing
-
In November, China's propylene oxide market first rose then fell